Infections in Patients with Rheumatoid Arthritis in the Era of Targeted Synthetic Therapies
The third decade of the 21st century marks the beginning of a new era in the treatment of rheumatoid arthritis (RA). Recently, after the introduction in clinical practice of different biologics in the first decade, three different oral synthetic targeted agents (JAK inhibitors) have been licensed fo...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PCO Convin S.A.
2020-01-01
|
| Series: | Mediterranean Journal of Rheumatology |
| Subjects: | |
| Online Access: | http://mjrheum.org/assets/files/792/file221_1142.pdf |